Cargando…

Potential Challenges for Coronavirus (SARS-CoV-2) Vaccines Under Trial

Detalles Bibliográficos
Autores principales:	Usmani, Salman Sadullah, Raghava, Gajendra P. S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7550622/ https://www.ncbi.nlm.nih.gov/pubmed/33133071 http://dx.doi.org/10.3389/fimmu.2020.561851

Ejemplares similares

A Web Resource for Designing Subunit Vaccine Against Major Pathogenic Species of Bacteria
por: Nagpal, Gandharva, et al.
Publicado: (2018)

Prediction of Antitubercular Peptides From Sequence Information Using Ensemble Classifier and Hybrid Features
por: Usmani, Salman Sadullah, et al.
Publicado: (2018)

The Comparative Immunological Characteristics of SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections
por: Zhang, Yun-yu, et al.
Publicado: (2020)

AntiTbPdb: a knowledgebase of anti-tubercular peptides
por: Usmani, Salman Sadullah, et al.
Publicado: (2018)

PRRDB 2.0: a comprehensive database of pattern-recognition receptors and their ligands
por: Kaur, Dilraj, et al.
Publicado: (2019)

Computer-aided designing of immunosuppressive peptides based on IL-10 inducing potential
por: Nagpal, Gandharva, et al.
Publicado: (2017)

ImmunoSPdb: an archive of immunosuppressive peptides
por: Usmani, Salman Sadullah, et al.
Publicado: (2019)

Prediction of Cell-Penetrating Potential of Modified Peptides Containing Natural and Chemically Modified Residues
por: Kumar, Vinod, et al.
Publicado: (2018)

The Mucosal and Serological Immune Responses to the Novel Coronavirus (SARS-CoV-2) Vaccines
por: Chan, Renee W. Y., et al.
Publicado: (2021)

mRNA Vaccine: How to Meet the Challenge of SARS-CoV-2
por: Jin, Yingqi, et al.
Publicado: (2022)

HumCFS: a database of fragile sites in human chromosomes
por: Kumar, Rajesh, et al.
Publicado: (2019)

Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
por: de Miranda Santos, Isabel Kinney Ferreira, et al.
Publicado: (2020)

CPPsite 2.0: a repository of experimentally validated cell-penetrating peptides
por: Agrawal, Piyush, et al.
Publicado: (2016)

CancerPDF: A repository of cancer-associated peptidome found in human biofluids
por: Bhalla, Sherry, et al.
Publicado: (2017)

IL-7 in SARS-CoV-2 Infection and as a Potential Vaccine Adjuvant
por: Bekele, Yonas, et al.
Publicado: (2021)

The Potential Effect of Novel Coronavirus SARS-CoV-2 on NK Cells; A Perspective on Potential Therapeutic Interventions
por: Jewett, Anahid
Publicado: (2020)

Persistence of SARS-CoV-2 Antibodies in Vaccinated Health Care Workers Analyzed by Coronavirus Antigen Microarray
por: Hosseinian, Sina, et al.
Publicado: (2022)

Serological responses triggered by different SARS-CoV-2 vaccines against SARS-CoV-2 variants in Taiwan
por: Chao, Chiao-Hsuan, et al.
Publicado: (2022)

SARS-CoV-2-Seronegative Subjects Target CTL Epitopes in the SARS-CoV-2 Nucleoprotein Cross-Reactive to Common Cold Coronaviruses
por: Schmidt, Katja G., et al.
Publicado: (2021)

Corrigendum: Impact of Hydroxychloroquine on Antibody Responses to the SARS-CoV-2 Coronavirus
por: Santos, Isabel Kinney Ferreira De Miranda, et al.
Publicado: (2020)

Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus
por: Shang, Yufeng, et al.
Publicado: (2021)

SARS-CoV-2 Variants, Vaccines, and Host Immunity
por: Mistry, Priyal, et al.
Publicado: (2022)

Adherence to Sars-CoV2 vaccination in hematological patients
por: Narinx, Justine, et al.
Publicado: (2022)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains
por: Lee, Chloe H., et al.
Publicado: (2020)

Potential Cross-Reactive Immunity to SARS-CoV-2 From Common Human Pathogens and Vaccines
por: Reche, Pedro A.
Publicado: (2020)

Comparative Review of SARS-CoV-2, SARS-CoV, MERS-CoV, and Influenza A Respiratory Viruses
por: Abdelrahman, Zeinab, et al.
Publicado: (2020)

The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development
por: Alturki, Sana O., et al.
Publicado: (2020)

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis
por: Woopen, Christina, et al.
Publicado: (2021)

Role of COVID-19 Vaccines in SARS-CoV-2 Variants
por: Zhou, Zhou, et al.
Publicado: (2022)

SARS-CoV-2 epitopes inform future vaccination strategies
por: Shafqat, Areez, et al.
Publicado: (2022)

Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell Immunity
por: Scaglione, Antonella, et al.
Publicado: (2021)

Effects of SARS-CoV-2 Alpha, Beta, and Delta variants, age, vaccination, and prior infection on infectiousness of SARS-CoV-2 infections
por: Qassim, Suelen H., et al.
Publicado: (2022)

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
por: Crowley, Andrew R, et al.
Publicado: (2022)

CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization
por: Haun, Brien K., et al.
Publicado: (2020)

Glycophosphopeptical AM3 Food Supplement: A Potential Adjuvant in the Treatment and Vaccination of SARS-CoV-2
por: Fernández-Lázaro, Diego, et al.
Publicado: (2021)

Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques
por: White, Andrew D., et al.
Publicado: (2022)

Potential SARS-CoV-2 Preimmune IgM Epitopes
por: Shivarov, Velizar, et al.
Publicado: (2020)

SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation
por: MacDougall, Madison, et al.
Publicado: (2022)

Recombinant Mycobacterium paragordonae Expressing SARS-CoV-2 Receptor-Binding Domain as a Vaccine Candidate Against SARS-CoV-2 Infections
por: Kim, Byoung-Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_qiv3fp9cno2vn4g8ttckgrp3dr